EP1677751A1 - Composition for treating bad breath - Google Patents
Composition for treating bad breathInfo
- Publication number
- EP1677751A1 EP1677751A1 EP04787564A EP04787564A EP1677751A1 EP 1677751 A1 EP1677751 A1 EP 1677751A1 EP 04787564 A EP04787564 A EP 04787564A EP 04787564 A EP04787564 A EP 04787564A EP 1677751 A1 EP1677751 A1 EP 1677751A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oxidase
- composition according
- enzyme
- composition
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 206010006326 Breath odour Diseases 0.000 title claims abstract description 17
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 21
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 21
- 210000000214 mouth Anatomy 0.000 claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 16
- 229920002472 Starch Polymers 0.000 claims abstract description 14
- 239000008107 starch Substances 0.000 claims abstract description 14
- 235000019698 starch Nutrition 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims abstract description 13
- -1 pseudohalogen ions Chemical class 0.000 claims abstract description 13
- 108010027912 Sulfite Oxidase Proteins 0.000 claims abstract description 11
- 102000043440 Sulfite oxidase Human genes 0.000 claims abstract description 11
- 239000001913 cellulose Substances 0.000 claims abstract description 7
- 229920002678 cellulose Polymers 0.000 claims abstract description 7
- 229940088598 enzyme Drugs 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 108010023244 Lactoperoxidase Proteins 0.000 claims description 12
- 235000019420 glucose oxidase Nutrition 0.000 claims description 12
- 229940057428 lactoperoxidase Drugs 0.000 claims description 12
- 239000004382 Amylase Substances 0.000 claims description 11
- 102000013142 Amylases Human genes 0.000 claims description 11
- 108010065511 Amylases Proteins 0.000 claims description 11
- 108010015776 Glucose oxidase Proteins 0.000 claims description 11
- 239000004366 Glucose oxidase Substances 0.000 claims description 11
- 235000019418 amylase Nutrition 0.000 claims description 11
- 229940116332 glucose oxidase Drugs 0.000 claims description 11
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 102100022624 Glucoamylase Human genes 0.000 claims description 7
- 108010059892 Cellulase Proteins 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 230000001055 chewing effect Effects 0.000 claims description 6
- 150000004820 halides Chemical class 0.000 claims description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- 206010039424 Salivary hypersecretion Diseases 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 108010018734 hexose oxidase Proteins 0.000 claims description 5
- 239000002324 mouth wash Substances 0.000 claims description 5
- 229940051866 mouthwash Drugs 0.000 claims description 5
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 claims description 5
- 229940116357 potassium thiocyanate Drugs 0.000 claims description 5
- 210000003296 saliva Anatomy 0.000 claims description 5
- 208000026451 salivation Diseases 0.000 claims description 5
- 101710112892 Alditol oxidase Proteins 0.000 claims description 4
- 102000010445 Lactoferrin Human genes 0.000 claims description 4
- 108010063045 Lactoferrin Proteins 0.000 claims description 4
- 102000016943 Muramidase Human genes 0.000 claims description 4
- 108010014251 Muramidase Proteins 0.000 claims description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 4
- 239000002535 acidifier Substances 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 4
- 229940078795 lactoferrin Drugs 0.000 claims description 4
- 235000021242 lactoferrin Nutrition 0.000 claims description 4
- 239000004325 lysozyme Substances 0.000 claims description 4
- 229960000274 lysozyme Drugs 0.000 claims description 4
- 235000010335 lysozyme Nutrition 0.000 claims description 4
- 239000006072 paste Substances 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 229940034610 toothpaste Drugs 0.000 claims description 4
- 239000000606 toothpaste Substances 0.000 claims description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 3
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 3
- 229940095602 acidifiers Drugs 0.000 claims description 3
- 239000002269 analeptic agent Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 239000006172 buffering agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 150000003567 thiocyanates Chemical class 0.000 claims description 3
- LJCNDNBULVLKSG-UHFFFAOYSA-N 2-aminoacetic acid;butane Chemical compound CCCC.CCCC.NCC(O)=O LJCNDNBULVLKSG-UHFFFAOYSA-N 0.000 claims description 2
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 2
- 108091023020 Aldehyde Oxidase Proteins 0.000 claims description 2
- 102000048262 Aldehyde oxidases Human genes 0.000 claims description 2
- 108010035722 Chloride peroxidase Proteins 0.000 claims description 2
- 108010015133 Galactose oxidase Proteins 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 2
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 claims description 2
- 102000003896 Myeloperoxidases Human genes 0.000 claims description 2
- 108090000235 Myeloperoxidases Proteins 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 150000003841 chloride salts Chemical class 0.000 claims description 2
- 239000000001 dental powder Substances 0.000 claims description 2
- 108010062584 glycollate oxidase Proteins 0.000 claims description 2
- 150000004694 iodide salts Chemical class 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229940041672 oral gel Drugs 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 108010001816 pyranose oxidase Proteins 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 claims 3
- 102100038609 Lactoperoxidase Human genes 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 102000003992 Peroxidases Human genes 0.000 abstract description 9
- 239000012876 carrier material Substances 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 18
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 14
- 102000045576 Lactoperoxidases Human genes 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 150000003464 sulfur compounds Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 241000206575 Chondrus crispus Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 235000019568 aromas Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- ZCZCOXLLICTZAH-UHFFFAOYSA-N hypothiocyanous acid Chemical compound OSC#N ZCZCOXLLICTZAH-UHFFFAOYSA-N 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 3
- 229960002218 sodium chlorite Drugs 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001147496 Mazzaella flaccida Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 229940095710 chewable product Drugs 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VRYALKFFQXWPIH-HSUXUTPPSA-N 2-deoxy-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-HSUXUTPPSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- OBFSQMXGZIYMMN-UHFFFAOYSA-N 3-chloro-2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=NC=CC=C1Cl OBFSQMXGZIYMMN-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001149957 Cladosporium oxysporum Species 0.000 description 1
- 241001207508 Cladosporium sp. Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241001557886 Trichoderma sp. Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019000 fluorine Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940097042 glucuronate Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Chemical class 0.000 description 1
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- WFZDJVVPNDVRGZ-UHFFFAOYSA-N thiocyanatooxy thiocyanate Chemical compound N#CSOSC#N WFZDJVVPNDVRGZ-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
Definitions
- the patent US 5336494 describes a chewable product, coated enzymatically, which during chewing produces anti-bacterial effects in the oral cavity by activation of the enzymatic system contained in the coating.
- the enzymatic coating comprises an oxidizable substrate such as for example Beta-D-Glucose, an oxidoreductase enzyme specific for said substrate such as glucose oxidase, in order to produce hydrogen peroxide during the chewing of said coated product, said coated product may also contain a peroxidase enzyme such as for example lactoperoxidase and an alkali metal salt (such as for example thiocyanate) in order to interact with hydrogen peroxide and produce an anionic oxidized bacterial inhibitor.
- a peroxidase enzyme such as for example lactoperoxidase and an alkali metal salt (such as for example thiocyanate) in order to interact with hydrogen peroxide and produce an anionic oxidized bacterial inhibitor.
- Glycerin (humidifying agent) 40,000 g
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a composition suitable for treating bad breath and including a carrier material, at least one enzyme sulphite oxidase, an enzyme for breaking down the starch and/or cellulose present in the oral cavity to give glucose, an enzyme oxidoreductase, a source of halogen or pseudohalogen ions, and an enzyme peroxidase.
Description
COMPOSITION POUR LE TRAITEMENT DE LA MAUVAISE HALEINE COMPOSITION FOR THE TREATMENT OF BAD BREATH
La présente invention a pour objet une composition pour le traitement de la mauvaise haleine chez l'homme ou l'animal comprenant un mélange d'enzymes. La mauvaise haleine affecte de nombreuses personnes, ce qui constitue un sérieux problème, tant pour celles souffrant de mauvaise haleine que pour l'entourage de ces personnes, car cette situation engendre de l' inconfort mutuel et peut ainsi créer des tensions sociales. De la même façon, la mauvaise haleine chez les animaux de compagnie est une des causes principales du comportement négatif du propriétaire envers son chien ou son chat. Le fait que l'animal de compagnie vive dans la maison ou l'appartement du propriétaire implique que le confort ou l' inconfort d'avoir un animal ayant une mauvaise haleine est important pour le propriétaire . La mauvaise haleine est un problème que l'on retrouve fréquemment chez les animaux, notamment chez les animaux de compagnie avec une petite bouche, car leur bouche n'est pas régulièrement aérée et mal oxygénée. Dans les conditions anaérobes, il y a une majorité de bactéries qui sont la cause de la putréfaction. Les études menées à ce jour ont montré que les principaux composés responsables de la mauvaise haleine sont les composés volatils soufrés, c'est-à-dire le sulfure de dihydrogène (H2S) , le méthane thiol (CH3SH) et le sulfure de diméthyle (CH3SCH3) . Ces composés sont dus à la dégradation par les bactéries anaérobes dans la cavité orale des protéines contenant du soufre. De nombreuses compositions destinées à combattre la mauvaise haleine ont été décrites à ce jour. Il est courant d'utiliser des préparations à base de chlorhexidine permettant de lutter contre les bactéries qui sont la cause de la dégradation des protéines dans la bouche.
Ainsi, le brevet EP 920857 décrit une composition orale comprenant a) du digluconate de chlorhexidine, b) du chlorure de cétyl pyridinium et c) un sel pharmaceutiquement acceptable ou un composé de Zn2+ et/ou de Cu2+. De telles préparations présentent des effets secondaires tels que la coloration des dents, le changement de goût dans la bouche etc.... On connaît également des préparations à base de chlorite de sodium, qui constitue la source de l'oxygène qui oxyde les composés volatils soufrés vers des substances sans odeur. Ainsi, le brevet US6325997 décrit une préparation comprenant du chlorite de sodium (NaC102) et un ion métallique tel que du zinc pouvant former un complexe avec un composé soufré. L' inconvénient des préparations à base de chlorite de sodium est la stabilité très limitée des produits qui fournissent l'oxygène. En effet, une solution oxygénée perd son activité oxydante dans le temps (date de péremption limitée à 2 à 3 mois pour l'eau oxygénée) . On a également proposé des préparations à base de zinc formant une composition non soluble avec les composés volatils soufrés, lesdites préparations étant abs'orbées par la voie orale et digérées. Ainsi, la demande 099/17735 décrit une composition comprenant un chélate comprenant un ion métal, de préférence un ion zinc, et un acide aminé, de préférence la glycine, ledit chélate étant libéré de façon contrôlée dans la cavité orale du sujet présentant la mauvaise haleine. Cependant les contre-indications des préparations à base de zinc sont nombreuses : cas d'hypersensiblité au zinc, interactions possibles avec des médicaments, avec des suppléments nutritionnels, contre-indication en cas de grossesse, d'allaitement, effets secondaires (inconfort gastrique, nausées, vomissements, mal de tête, somnolence, goût métallique dans la bouche etc ...) .
On connaît également des produits à base d'enzymes destinés à lutter contre la mauvaise haleine. Le brevet US4564519 décrit un dentifrice à mâcher di-enzymatique comprenant, par exemple du glucose et du glucose oxydase afin de produire du peroxyde d'hydrogène lors de la mastication du dentifrice, et comprenant en outre un sel thiocyanate et une lactoperoxydase pour interagir avec le peroxyde d'hydrogène et produire un inhibiteur bactérien hypothiocyanate . Le brevet US 5336494 décrit un produit à mâcher, enrobé enzymatiquement, qui lors de la mastication produit des effets anti-bactériens dans la cavité orale par activation du système enzymatique contenu dans l'enrobage. L'enrobage enzymatique comprend un substrat oxydable tel que par exemple du Beta-D-Glucose, une enzyme oxydoréductase spécifique dudit substrat telle que la glucose oxydase, afin de produire du peroxyde d'hydrogène lors de la mastication dudit produit enrobé, ledit produit enrobé pouvant en outre contenir une enzyme peroxydase telle que par exemple la lactoperoxydase et un sel de métal alcalin (tel que par exemple le thiocyanate) afin d' interagir avec le peroxyde d'hydrogène et produire un inhibiteur bactérien oxydé anionique . Le brevet EP658096 décrit un produit à mâcher antimicrobien pour animaux, comprenant un matériau support, au moins une enzyme oxydoréductase (telle que la glucose oxydase, la sulfite oxydase) , au moins un substrat pour oxydoréductase (tel que le D-glucose) et une catalase (telle que celle dérivée de la fermentation d'Aspergillus niger) permettant de contrôler la production de peroxyde d'hydrogène. Le produit peut également contenir une enzyme peroxydase (par exemple la lactoperoxydase) et une source d'ions halogénure. Cependant, il est toujours nécessaire d'utiliser un substrat pour l'enzyme oxydoréductase, ce qui présente des inconvénients au niveau de la stabilité, tant au niveau de la fabrication du produit, qu'au niveau du produit fini.
La présente invention a pour objet une composition adéquate pour le traitement de la mauvaise haleine, comprenant : - un matériau support, - une enzyme sulfite oxydase, - au moins une enzyme permettant de décomposer en glucose, l'amidon et/ou la .cellulose présents dans la cavité orale, - une enzyme oxydoréductase, - une source d'ions halogénure ou pseudohalogénure, - une enzyme peroxydase. On entend par matériau support tout matériau permettant de rendre agréable pour la cavité orale de l'animal ou de l'homme la composition objet de l'invention. A titre d' exemple de matériau support pouvant être utilisé on pourra citer la pâte dentaire, le collagène, tout produit non toxique restant le temps nécessaire pour obtenir une réaction dans la cavité orale, etc.... Le matériau support peut rester dans la cavité orale pendant une durée allant d'environ 5 secondes à environ 1 h. La quantité de matériau support varie d'environ 1% à environ 99% en poids par rapport au poids total de la composition de l'invention. L'enzyme sulfite oxidase permet de transformer les composés volatils soufrés présents dans la cavité orale et responsables de la mauvaise haleine, à savoir le sulfure de dihydrogène (H2S) , le méthane thiol (CH3SH) et le sulfure de diméthyle (CH3SCH3) , en composés inodores (à savoir en sulfone (S02) et en diméthylsulfone (CH3S02CH3) ) . La quantité d'enzyme sulfite oxydase varie d'environThe present invention relates to a composition for the treatment of bad breath in humans or animals comprising a mixture of enzymes. Bad breath affects many people, which is a serious problem, both for those with bad breath and for those around them, as this creates mutual discomfort and can thus create social tension. Likewise, bad breath in pets is one of the main causes of the owner's negative behavior towards his dog or cat. The fact that the pet lives in the owner's house or apartment implies that the comfort or discomfort of having an animal with bad breath is important to the owner. Bad breath is a problem that is frequently found in animals, especially in pets with a small mouth, because their mouth is not regularly ventilated and poorly oxygenated. In anaerobic conditions, there is a majority of bacteria that are the cause of putrefaction. Studies to date have shown that the main compounds responsible for bad breath are volatile sulfur compounds, i.e. dihydrogen sulfide (H 2 S), methane thiol (CH3SH) and sulfide. dimethyl (CH 3 SCH 3 ). These compounds are due to the degradation of sulfur-containing proteins by anaerobic bacteria in the oral cavity. Numerous compositions intended to combat bad breath have been described to date. It is common to use chlorhexidine preparations to fight the bacteria that are the cause of protein breakdown in the mouth. Thus, patent EP 920857 describes an oral composition comprising a) chlorhexidine digluconate, b) cetyl pyridinium chloride and c) a pharmaceutically acceptable salt or a compound of Zn 2+ and / or Cu 2+ . Such preparations have side effects such as coloring of the teeth, change of taste in the mouth, etc. Preparations based on sodium chlorite are also known, which constitutes the source of the oxygen which oxidizes the compounds. volatile sulfur to odorless substances. Thus, US Pat. No. 6,325,997 describes a preparation comprising sodium chlorite (NaC10 2 ) and a metal ion such as zinc which can form a complex with a sulfur compound. The drawback of preparations based on sodium chlorite is the very limited stability of the products which supply oxygen. Indeed, an oxygenated solution loses its oxidizing activity over time (expiration date limited to 2 to 3 months for hydrogen peroxide). Zinc-based preparations have also been proposed which form a composition that is not soluble with volatile sulfur compounds, said preparations being absorbed orally and digested. Thus, application 099/17735 describes a composition comprising a chelate comprising a metal ion, preferably a zinc ion, and an amino acid, preferably glycine, said chelate being released in a controlled manner in the oral cavity of the subject having bad breath. However, there are many contraindications for zinc-based preparations: cases of hypersensitivity to zinc, possible interactions with drugs, with nutritional supplements, contraindication in the event of pregnancy, breastfeeding, side effects (gastric discomfort, nausea, vomiting, headache, drowsiness, metallic taste in the mouth etc ...). Also known are products based on enzymes intended to fight against bad breath. The patent US4564519 describes a di-enzymatic chewing toothpaste comprising, for example glucose and glucose oxidase in order to produce hydrogen peroxide during the chewing of the toothpaste, and further comprising a thiocyanate salt and a lactoperoxidase to interact with the hydrogen peroxide and produce a bacterial inhibitor hypothiocyanate. The patent US 5336494 describes a chewable product, coated enzymatically, which during chewing produces anti-bacterial effects in the oral cavity by activation of the enzymatic system contained in the coating. The enzymatic coating comprises an oxidizable substrate such as for example Beta-D-Glucose, an oxidoreductase enzyme specific for said substrate such as glucose oxidase, in order to produce hydrogen peroxide during the chewing of said coated product, said coated product may also contain a peroxidase enzyme such as for example lactoperoxidase and an alkali metal salt (such as for example thiocyanate) in order to interact with hydrogen peroxide and produce an anionic oxidized bacterial inhibitor. Patent EP658096 describes an antimicrobial chewable product for animals, comprising a support material, at least one oxidoreductase enzyme (such as glucose oxidase, sulfite oxidase), at least one substrate for oxidoreductase (such as D-glucose) and a catalase (such as that derived from the fermentation of Aspergillus niger) to control the production of hydrogen peroxide. The product may also contain a peroxidase enzyme (eg lactoperoxidase) and a source of halide ions. However, it is still necessary to use a substrate for the oxidoreductase enzyme, which has disadvantages in terms of stability, both in terms of manufacturing the product and in terms of the finished product. The subject of the present invention is a composition suitable for the treatment of bad breath, comprising: - a support material, - a sulfite oxidase enzyme, - at least one enzyme making it possible to decompose into glucose, starch and / or .cellulose present in the oral cavity, - an oxidoreductase enzyme, - a source of halide or pseudohalide ions, - a peroxidase enzyme. The term “support material” means any material making it possible to make the composition object of the invention pleasant for the oral cavity of the animal or of the man. As an example of a support material that can be used, mention may be made of dental paste, collagen, any non-toxic product remaining the time necessary to obtain a reaction in the oral cavity, etc. The support material can remain in the oral cavity for a period ranging from approximately 5 seconds to approximately 1 hour. The amount of support material varies from about 1% to about 99% by weight relative to the total weight of the composition of the invention. The sulfite oxidase enzyme transforms the volatile sulfur compounds present in the oral cavity and responsible for bad breath, namely dihydrogen sulfide (H 2 S), methane thiol (CH 3 SH) and dimethyl sulfide ( CH 3 SCH 3 ), odorless compounds (namely sulfone (S0 2 ) and dimethyl sulfone (CH 3 S0 2 CH 3 )). The amount of sulfite oxidase enzyme varies from around
0,2 UI à environ 2000 UI . Le terme « UI » signifie « Unité Internationale » et désigne la quantité d' enzymes permettant la catalyse de 1 micromole de composé par unité à un pH de 7.0 et une température de 25 °C.
L'enzyme permettant de décomposer en glucose, l'amidon et/ou la cellulose présents dans la cavité orale, est choisie dans le groupe constitué par l'amylase, la cellulase, la glucoamylase et leurs mélanges. La quantité d'enzyme permettant de décomposer en glucose, l'amidon et/ou la cellulose, varie d'environ 0,05% à environ 30% en poids par rapport au poids total de la composition de l'invention. L'amidon et/ou la cellulose présents dans la cavité orale proviennent des résidus de nourriture. A titre d'exemple, l'alimentation quotidienne des animaux de compagnie, notamment des chiens, est constituée principalement de céréales qui contiennent de l'amidon. Afin d'utiliser l'amidon pour sa valeur énergétique, une enzyme spécifique doit réagir pour libérer le glucose : l'amylase ou la glucoamylase. La salive des chiens (contrairement à celle de l'homme) ne contient pas d' amylase (l'amylase existe chez les chiens uniquement dans les intestins) . L'utilisation d'une enzyme amylase, cellulase et/ou glucoamylase permet avantageusement que : - l'amidon qui reste entre les dents (notamment les dents des chiens) soit alors détruit en particules de glucose qui sont prêtes à servir de substrat pour la réaction « glucose oxydase », « lactoperoxydase », - l'amidon ne soit pas utilisable comme substrat pour la formation de la plaque dentaire (sinon l'amidon reste dans la bouche des chiens et reste un substrat pour les bactéries) L'enzyme oxydoréductase permet d'oxyder les particules de glucose en glucuronate et peroxyde d'hydrogène. L'enzyme oxydoréductase est choisie dans le groupe constitué par la glucose oxydase, la galactose oxydase, la glycollate oxydase, l'aldéhyde oxydase, la lactate oxydase, la xantine oxydase, l'acide aminé-L oxydase, l'acide aminé-D oxydase, la monophosphate oxydase, l'hexose oxydase, la
xylitol oxydase, la pyranose oxydase, l'alcool oxydase et leurs mélanges. La quantité d'enzyme oxydoréductase varie d'environ 0,2 UI à environ 2000 UI . Une enzyme glucose oxydase appropriée est par exemple celle provenant de l' Aspergillus sp . ou d'une souche d' Aspergillus niger ou d'une souche de Cladosporium sp., en particulier Cladosporium oxysporum. Une enzyme acide aminé-L oxydase pouvant convenir peut par exemple être celle décrite dans W094/25574 ou celle dérivée d'une Trichoderma sp. comme le Trichoderma harzianum, ou Trichoderma viride . Une enzyme hexose oxydase appropriée est par exemple celle provenant des algues rouges Chondrus crispus ou Iridophycus flaccidum. Les hexoses oxydases de l'algue rouge Chondrus crispus (plus connus sous la dénomination d'Irish moss) (Sullivan and I awa (1973), Biochim. Biophys . Acts, 309, p.11-22 ; Ikawa (1982), Meth. In Enzymol. 89, carbohydrate metabolism part D, 145-149) oxydent un large spectre de carbohydrates, comme D-glucose, D-glucose 6-phasphate, D- galactose, maltose, cellobiose, lactose, D-mannose, 2-deoxy-D- glucole, 2-deoxy-D-galactose, D-fucase et D-xylose. Les hexoses oxydases de l'algue rouge Iridophycus flaccidum oxydent également différents mono- et disaccharides (Bean and Hassid (1956), J. Biol. Chem. , 218, p.425 ; Rand et al. (1972, J. of Food Science 37, p.698-710). L'enzyme xylitol oxydase pouvant convenir est par exemple celle décrite dans JP80892242 qui oxyde le xylitol, le D-sorbitol, le D-galactitol, le D-mannitol et le D-arabinitol en présence d'oxygène. Une xylitol oxydase peut-être obtenue à partir de souches de Streptomyces sp. (e.g. [Streptomyces] IKD472, FERM P-14339) . La source d'ions halogénure ou pseudohalogénure est choisie dans le groupe constitué par le thiocyanate de potassium, le thiocyanate de sodium, le thiocyanate
d'ammonium, d'autres sels thiocyanates, l'iodure de potassium, d'autres sels iodures, le chlorure de sodium, d'autres sels chlorures et leurs mélanges . La quantité d'ions halogénure ou pseudohalogénure varie d'environ 0,0001 mol/g à environ 0,1 mol/g de matériau support. L'enzyme peroxydase est choisie dans le groupe constitué par la lactoperoxydase, la superoxyde dismutase, la myéloperoxydase, la chloroperoxydase, la peroxydase du raifort, la peroxydase de la salive et leurs mélanges. La quantité d'enzyme peroxydase varie d'environ 0,1 Ul/g à environ 100 Ul/g de matériau support. L'enzyme peroxydase et la source d'ions halogénure ou pseudo-halogénure interagissent avec le peroxyde d'hydrogène pour produire un agent antibactérien hypothiocyanate (OSCN" /HOSCN) . La lactoperoxydase est une enzyme naturellement présente dans la salive. Cependant des peroxydases additionnelles telles que celles citées ci-dessus peuvent être ajoutées, et notamment la superoxyde dismutase qui a une action beaucoup plus rapide que la lactoperoxydase. Selon un mode de réalisation avantageux de l'invention, la composition comprend en outre un agent stimulant la salivation, notamment choisi dans le groupe constitué par les émulsifiants saturés ou non, les acidifiants et leurs mélanges. A titre d'exemples d' émulsifiants, on pourra citer les alkyls aryls sulfonates, les alkyls sulfates, les amides et aminés sulfonées, les esters et éthers sulfatés et sulfonés, les alkyls sulfonates, les esters polyéthoxylés, les mono- et diglycérides, les esters diacétyl tartariques de monoglycérides, les esters de polyglycérol, les esters de sorbitanne et éthoxylates, les esters lactylés, les phospholipides tels que la lécithine, les esters polyoxyéthylène de sorbitanne, les esters de propylène glycols, les esters de sucrose et leurs mélanges. On citera
plus particulièrement le sorbitol à titre d'exemple d' émulsifiant . A titre d'exemples d'acidifiants, on pourra citer l'acide citrique, l'acide malique, le tartarate, le chlorure de sodium, le chlorure de potassium et leurs mélanges. Un acidificant particulièrement approprié est l'acide citrique. L'agent stimulant la salivation permet à la réaction de transformation de l'amidon en glucose de bien se passer, en permettant que le plus d'amidon possible soit imprégné d' amylase. La salive, qui est déjà présente en plus grande quantité, va être utilisée comme moyen de transport dans la cavité orale. Selon un autre mode de réalisation avantageux de l'invention, la composition comprend en outre un agent tampon permettant d'obtenir une composition présentant un pH d'environ 4 à environ 8, de préférence d'environ 5,4 à environ 6, 5. Un agent tampon approprié comprend le phosphate de potassium monobasique, le phosphate de potassium dibasique, le phosphate de sodium monobasique, le phosphate de sodium dibasique, le bicarbonate de sodium, l'hydroxyde de sodium, l'hydroxyde de potassium, l'acide citrique, l'acide benzoïque, l'acide malique etc .... Le maintien du pH entre 4 et 8, de préférence entre 5,4 et 6,5 permet de favoriser la concentration de l'agent antibactérien hypothiocyanate dans l'équilibre HOSCN/OSCN", ce qui est avantageux car il a été établi que le HOSCN est plus actif que le OSCN" contre les bactéries, parce que le HOSCN est neutre et pénètre plus facilement dans la cellule bactérienne. Selon un autre mode de réalisation avantageux de l'invention, la composition comprend en outre un agent aromatisant pouvant encore être appelé "agent stimulant aromatisé de salivation". A titre d'exemple on pourra citer
les arômes tels que les arômes de poulet ou les arômes de poisson . Selon un autre mode de réalisation avantageux de l'invention, la composition comprend en outre un agent enzymatique antibactérien, choisi dans le groupe constitué par le lysozyme, la lactoferrine et leurs mélanges. Le lysozyme permet de détruire la membrane des bactéries et la lactoferrine permet d'absorber tout le fer qui est l'élément essentiel pour la survie des bactéries pathogènes Selon un autre mode de réalisation avantageux de l'invention, la composition comprend des véhicules et excipients appropriés pour une administration par voie orale. La composition de l'invention peut comprendre un agent anticaries (fluor, fluorure de sodium, lactate de calcium etc... ) , un agent anti-plaque (ion de zinc, sanguinarine etc... ) un agent anti-tartre (sels de pyrophosphate, polyphosphate, hexaméthaphosphate etc....), un agent antibactérien (chlorhexidine, phénoxyéthanol, parabène etc... ) , un agent anti-inflammatoire (ibuprofène, acide méclofénamique etc... ) , un agent inhibiteur de proteases impliquées dans le processus inflammatoire (métalloprotine, serinneprotéinase etc... ) , un agent antiseptique (miconazole, aciclovir etc..) etc. . Elle peut également comprendre un agent humidifiant (glycérine, propylèneglycol, polyéthylèneglycol, sorbitol, mannitol, xylitol etc.) , un agent épaississant (carraghenine, méthylcellulose, silicagel (Tixosil®) , colloïde Mg-Al-Silice etc... ) , un agent abrasif (phosphate de calcium, silice, urée formaldéhyde, Tixosil® etc. ) , un agent tensioactif de structure anionique (par exemple le laurylsulfate de sodium etc... ) , de structure cationique (fluorure de cétylpyridine, chlorure de cétylpyridine etc... ) , de structure non-ionique (tels que des produits de condensation d'oxyde d' éthylène avec du propylène-glycol (produits de la série Pluronic® ) etc... ) , un agent anti-oxydant (vitamine A, cystéine, glutathion, coenzyme Q-10 etc... ) , un agent édulcorant (glucose,
saccharose, lactose, acesulfaam • etc.. ), un agent rafraîchissant (menthol, carboxamide etc. ) , un agent réchauffant (capsicum, poivron etc. ) , un agent neutralisant (essence de girofle, lidocaïne etc.) , un agent émulsifiant (compositions polymériques telles que le polyvinylméthyléther etc.), un agent facilitant l'adhérence de la substance active au support (gommes naturelles etc. ) , un agent conservateur (hydroxyméthyle, hydroxypropyle parabène etc. ) , un agent de blanchiment (peroxyde d'urée, peroxyde d'hydrogène etc. ), un agent colorant (bleu de méthylène etc. ), de l'eau. La composition selon l'invention se présente sous une forme orale liquide, sous une forme orale solide etc.... Plus particulièrement, la composition de l'invention se présente par exemple sous forme d'un dentifrice, d'une lamelle à mâcher, d'un chewing-gum, d'un collutoire pour bain de bouche, d'un gel buccal, d'une poudre dentaire, d'un comprimé à mâcher, d'une pâte à mâcher etc.... La présente invention a également pour objet l'utilisation d'une composition telle que décrite ci-dessus pour le traitement de la mauvaise haleine chez l'homme ou chez 1' animal. Les compositions de l'invention ne nécessitent pas l'utilisation d'un substrat pour l'enzyme oxydoréductase, ce qui présente notamment l'avantage de ne pas avoir, une oxydation du glucose par le glucose oxydase afin de former le peroxyde qui, au moment venu, va oxyder le thiocyanate en oxythiocyanate . Les compositions de l'invention présentent une stabilité prolongée dans le temps, pouvant aller jusqu'à 60 mois.0.2 IU to approximately 2000 IU. The term "IU" means "International Unit" and designates the quantity of enzymes allowing the catalysis of 1 micromole of compound per unit at a pH of 7.0 and a temperature of 25 ° C. The enzyme making it possible to decompose into glucose, the starch and / or the cellulose present in the oral cavity, is chosen from the group consisting of amylase, cellulase, glucoamylase and their mixtures. The amount of enzyme making it possible to decompose into glucose, starch and / or cellulose, varies from approximately 0.05% to approximately 30% by weight relative to the total weight of the composition of the invention. The starch and / or cellulose present in the oral cavity comes from food residues. For example, the daily diet of pets, especially dogs, consists mainly of cereals which contain starch. In order to use starch for its energy value, a specific enzyme must react to release glucose: amylase or glucoamylase. Dog saliva (unlike that of humans) does not contain amylase (amylase exists in dogs only in the intestines). The use of an amylase, cellulase and / or glucoamylase enzyme advantageously allows: - the starch which remains between the teeth (in particular the teeth of dogs) is then destroyed in glucose particles which are ready to serve as substrate for the reaction “glucose oxidase”, “lactoperoxidase”, - starch cannot be used as a substrate for the formation of dental plaque (otherwise the starch remains in the mouth of dogs and remains a substrate for bacteria) The enzyme oxidoreductase oxidizes glucose particles to glucuronate and hydrogen peroxide. The oxidoreductase enzyme is chosen from the group consisting of glucose oxidase, galactose oxidase, glycollate oxidase, aldehyde oxidase, lactate oxidase, xantine oxidase, amino acid-L oxidase, amino acid-D oxidase, monophosphate oxidase, hexose oxidase, xylitol oxidase, pyranose oxidase, alcohol oxidase and mixtures thereof. The amount of oxidoreductase enzyme varies from about 0.2 IU to about 2000 IU. A suitable glucose oxidase enzyme is, for example, that originating from Aspergillus sp. or a strain of Aspergillus niger or a strain of Cladosporium sp., in particular Cladosporium oxysporum. A suitable amino acid-L oxidase enzyme may for example be that described in WO94 / 25574 or that derived from Trichoderma sp. such as Trichoderma harzianum, or Trichoderma viride. A suitable hexose oxidase enzyme is, for example, that obtained from the red algae Chondrus crispus or Iridophycus flaccidum. The hexose oxidases of the red alga Chondrus crispus (better known under the name of Irish moss) (Sullivan and I awa (1973), Biochim. Biophys. Acts, 309, p.11-22; Ikawa (1982), Meth In Enzymol. 89, carbohydrate metabolism part D, 145-149) oxidize a broad spectrum of carbohydrates, such as D-glucose, D-glucose 6-phasphate, D-galactose, maltose, cellobiose, lactose, D-mannose, 2- deoxy-D-glucole, 2-deoxy-D-galactose, D-fucase and D-xylose. The hexose oxidases of the red alga Iridophycus flaccidum also oxidize different mono- and disaccharides (Bean and Hassid (1956), J. Biol. Chem., 218, p.425; Rand et al. (1972, J. of Food Science 37, p.698-710). The suitable xylitol oxidase enzyme is for example that described in JP80892242 which oxidizes xylitol, D-sorbitol, D-galactitol, D-mannitol and D-arabinitol in the presence of A xylitol oxidase can be obtained from strains of Streptomyces sp. (eg [Streptomyces] IKD472, FERM P-14339). The source of halide or pseudohalide ions is chosen from the group consisting of potassium thiocyanate , sodium thiocyanate, thiocyanate ammonium, other thiocyanate salts, potassium iodide, other iodide salts, sodium chloride, other chloride salts and mixtures thereof. The amount of halide or pseudohalide ions varies from about 0.0001 mol / g to about 0.1 mol / g of support material. The peroxidase enzyme is selected from the group consisting of lactoperoxidase, superoxide dismutase, myeloperoxidase, chloroperoxidase, horseradish peroxidase, saliva peroxidase and mixtures thereof. The amount of peroxidase enzyme varies from about 0.1 IU / g to about 100 IU / g of support material. The enzyme peroxidase and the source of halide or pseudohalide ions interact with hydrogen peroxide to produce an antibacterial agent hypothiocyanate (OSCN " / HOSCN). Lactoperoxidase is an enzyme naturally present in saliva. However, additional peroxidases such as those mentioned above can be added, and in particular superoxide dismutase which has a much faster action than lactoperoxidase. According to an advantageous embodiment of the invention, the composition also comprises a salivation stimulating agent, in particular chosen from the group consisting of saturated or unsaturated emulsifiers, acidifiers and mixtures thereof As examples of emulsifiers, mention may be made of alkyl aryl sulfonates, alkyl sulfates, sulfonated amides and amines, sulfated esters and ethers and sulfonated, alkyl sulfonates, polyethoxylated esters, mono- and diglycerides, diacetyl tartaric esters s of monoglycerides, polyglycerol esters, sorbitan esters and ethoxylates, lactyl esters, phospholipids such as lecithin, polyoxyethylene sorbitan esters, propylene glycol esters, sucrose esters and mixtures thereof. We will quote more particularly sorbitol as an example of an emulsifier. Examples of acidifiers include citric acid, malic acid, tartarate, sodium chloride, potassium chloride and mixtures thereof. A particularly suitable acidifying agent is citric acid. The salivation stimulating agent allows the reaction to transform starch into glucose to go well, allowing as much starch as possible to be impregnated with amylase. Saliva, which is already present in larger quantities, will be used as a means of transport in the oral cavity. According to another advantageous embodiment of the invention, the composition further comprises a buffering agent making it possible to obtain a composition having a pH of from approximately 4 to approximately 8, preferably from approximately 5.4 to approximately 6.5. A suitable buffering agent includes monobasic potassium phosphate, dibasic potassium phosphate, monobasic sodium phosphate, dibasic sodium phosphate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, acid. citric, benzoic acid, malic acid etc. The maintenance of the pH between 4 and 8, preferably between 5.4 and 6.5 makes it possible to promote the concentration of the antibacterial agent hypothiocyanate in the equilibrium HOSCN / OSCN " , which is advantageous because it has been established that HOSCN is more active than OSCN " against bacteria, because HOSCN is neutral and enters the bacterial cell more easily. According to another advantageous embodiment of the invention, the composition also comprises a flavoring agent which can also be called "flavored stimulating salivation agent". As an example, we can cite aromas such as chicken aromas or fish aromas. According to another advantageous embodiment of the invention, the composition also comprises an antibacterial enzymatic agent, chosen from the group consisting of lysozyme, lactoferrin and their mixtures. Lysozyme makes it possible to destroy the membrane of bacteria and lactoferrin makes it possible to absorb all the iron which is the essential element for the survival of pathogenic bacteria According to another advantageous embodiment of the invention, the composition comprises vehicles and excipients suitable for oral administration. The composition of the invention can comprise an anticaries agent (fluorine, sodium fluoride, calcium lactate etc ...), an anti-plaque agent (zinc ion, sanguinarine etc ...) an anti-tartar agent (salts pyrophosphate, polyphosphate, hexamethaphosphate etc ...), an antibacterial agent (chlorhexidine, phenoxyethanol, paraben etc ...), an anti-inflammatory agent (ibuprofen, meclofenamic acid etc ...), an agent inhibiting proteases involved in the inflammatory process (metalloprotine, serinneproteinase etc ...), an antiseptic agent (miconazole, aciclovir etc ...) etc. . It can also include a humidifying agent (glycerin, propylene glycol, polyethylene glycol, sorbitol, mannitol, xylitol etc.), a thickening agent (carrageenan, methylcellulose, silica gel (Tixosil®), colloid Mg-Al-Silica etc.) abrasive agent (calcium phosphate, silica, urea formaldehyde, Tixosil® etc.), a surfactant with an anionic structure (for example sodium lauryl sulfate etc ...), cationic structure (cetylpyridine fluoride, cetylpyridine chloride etc.) ..), non-ionic structure (such as condensation products of ethylene oxide with propylene glycol (products of the Pluronic® series) etc ...), an antioxidant (vitamin A, cysteine, glutathione, coenzyme Q-10 etc ...), a sweetening agent (glucose, sucrose, lactose, acesulfaam • etc.), a refreshing agent (menthol, carboxamide etc.), a heating agent (capsicum, pepper etc.), a neutralizing agent (clove essence, lidocaine etc.), an emulsifying agent ( polymeric compositions such as polyvinyl methyl ether etc.), an agent facilitating the adhesion of the active substance to the support (natural gums etc.), a preservative (hydroxymethyl, hydroxypropyl paraben etc.), a bleaching agent (urea peroxide , hydrogen peroxide etc.), a coloring agent (methylene blue etc.), water. The composition according to the invention is presented in a liquid oral form, in a solid oral form, etc. More particularly, the composition of the invention is presented, for example, in the form of a toothpaste, a chewing strip , a chewing gum, a mouthwash mouthwash, an oral gel, a dental powder, a chewable tablet, a chewy paste, etc. The present invention also relates to the use of a composition as described above for the treatment of bad breath in humans or in animals. The compositions of the invention do not require the use of a substrate for the oxidoreductase enzyme, which has in particular the advantage of not having an oxidation of glucose by glucose oxidase in order to form the peroxide which, at when the time comes, will oxidize the thiocyanate to oxythiocyanate. The compositions of the invention exhibit prolonged stability over time, which can range up to 60 months.
Les exemples suivants illustrent l'invention, ils ne la limitent en aucune façon.
Exemple 1 : DentrificeThe following examples illustrate the invention, they do not limit it in any way. Example 1: Dentrifice
Glycérine (agent humidifiant) 40,000 gGlycerin (humidifying agent) 40,000 g
Eau (transporteur) 5,000 g Tixosil 73 (agent épaississant et abrasif) 40,000 gWater (transporter) 5,000 g Tixosil 73 (thickening and abrasive agent) 40,000 g
Phosphate dicalcique (tampon) 5,000 gDicalcium phosphate (buffer) 5,000 g
Agent aromatisant 5,000 gFlavoring agent 5,000 g
Thiocyanate de potassium 0,010 gPotassium thiocyanate 0.010 g
Lactoperoxydase 0,010 g Glucose oxydase (208 UI) 0,010 gLactoperoxidase 0.010 g Glucose oxidase (208 IU) 0.010 g
Sulphite oxydase 0,010 gSulphite oxidase 0.010 g
Glucoamylase 0,200 gGlucoamylase 0.200 g
Amylase 0,010 gAmylase 0.010 g
Cellulase 0,200 gCellulase 0.200 g
Exemple 2 : Solution à déposer sur du collagèneExample 2: Solution to be deposited on collagen
Eau (transporteur) 40,000 gWater (carrier) 40,000 g
Carragène (agent épaississant) 1,500 g Agent aromatisant 5,000 g-Carrageenan (thickening agent) 1,500 g Flavoring agent 5,000 g-
Thiocyanate de potassium 0,010 gPotassium thiocyanate 0.010 g
Lactoperoxydase 0,010 gLactoperoxidase 0.010 g
Glucose oxydase (208 UI) 0,010 gGlucose oxidase (208 IU) 0.010 g
Sulphite oxydase 0,010 g Glucoamylase 0,200 gSulphite oxidase 0.010 g Glucoamylase 0.200 g
Amylase 0,010 gAmylase 0.010 g
Cellulase 0,200 gCellulase 0.200 g
Exemple 3 : Collutoire pour bain de boucheEXAMPLE 3 Mouthwash Mouthwash
Eau (matériau support) 80,000 gWater (support material) 80,000 g
Propylene glycol (agent humidifiant) 15,000 gPropylene glycol (humidifying agent) 15,000 g
Agent aromatisant 4,500 gFlavoring agent 4,500 g
Thiocyanate de potassium 0,010 g Lactoperoxydase 0,010 g
Glucose oxydase (208 UI) 0,010 g Sulphite oxydase 0,010 g Glucoamylase 0,200 g Amylase 0,010 g Cellulase 0,200 gPotassium thiocyanate 0.010 g Lactoperoxidase 0.010 g Glucose oxidase (208 IU) 0.010 g Sulphite oxidase 0.010 g Glucoamylase 0.200 g Amylase 0.010 g Cellulase 0.200 g
Exemple 4 : Pâte à mâcherExample 4: Chewy dough
Les pourcentages sont les pourcentages en poids par rapport au poids total de la composition.The percentages are the percentages by weight relative to the total weight of the composition.
Pâte (matériau support) 99% Glucoamylase 0,19% Amylase 0,01% Glucose oxydase 20 UI Sulphite oxydase 20 UI Lactoperoxydase 0,06% Métal alcalin ou sel 0,013% Lysozyme HCl 0,06% Lactoferrine 0,06% Benzoate de sodium 0,017% Tampon phosphate 0,14% Alginate ' 0,14% Arôme 0,1% Stimulant de salivation 0,30%
Paste (carrier material) 99% Glucoamylase 0.19% Amylase 0.01% Glucose oxidase 20 IU Sulphite oxidase 20 IU Lactoperoxidase 0.06% Alkali metal or salt 0.013% Lysozyme HCl 0.06% Lactoferrin 0.06% Sodium benzoate 0.017% Phosphate buffer 0.14% Alginate ' 0.14% Flavor 0.1% Salivation stimulant 0.30%
Claims
REVENDICATIONS
1 - Composition adéquate pour le traitement de la mauvaise haleine, comprenant : - un matériau support, - une enzyme sulfite oxydase, - au moins une enzyme permettant de décomposer en glucose, l'amidon et/ou la cellulose présents dans la cavité orale, - une enzyme oxydoréductase, - une source d' ions halogénure ou pseudohalogénure, - une enzyme peroxydase.1 - Composition suitable for the treatment of bad breath, comprising: - a support material, - a sulfite oxidase enzyme, - at least one enzyme making it possible to decompose into glucose, the starch and / or the cellulose present in the oral cavity, - an oxidoreductase enzyme, - a source of halide or pseudohalide ions, - a peroxidase enzyme.
2 - Composition selon la revendication 1, caractérisée en ce que la quantité de matériau support varie d'environ 1% à environ 99% en poids par rapport au poids total de la composition.2 - Composition according to claim 1, characterized in that the amount of support material varies from about 1% to about 99% by weight relative to the total weight of the composition.
3 - Composition selon la revendication 1 ou la revendication 2, caractérisée en ce que l.a quantité de sulfite oxydase varie d'environ 0,2 UI à environ 2000 UI.3 - Composition according to claim 1 or claim 2, characterized in that l.a amount of sulfite oxidase varies from about 0.2 IU to about 2000 IU.
4 - Composition selon l'une des revendications 1 à 3, caractérisée en ce que l'enzyme permettant de décomposer en glucose, l'amidon et/ou la cellulose présents dans la cavité orale, est choisie dans le groupe constitué par l'amylase, la cellulase, la glucoamylase et leurs mélanges, et en ce que la quantité de ladite enzyme varie d'environ 0,05% à environ 30% en poids par rapport au poids total de la composition.4 - Composition according to one of claims 1 to 3, characterized in that the enzyme making it possible to decompose into glucose, the starch and / or the cellulose present in the oral cavity, is chosen from the group consisting of amylase , cellulase, glucoamylase and mixtures thereof, and in that the amount of said enzyme varies from approximately 0.05% to approximately 30% by weight relative to the total weight of the composition.
5 - Composition selon l'une des revendications 1 à 4, caractérisée en ce que l'enzyme oxydoréductase est choisie dans le groupe constitué par la glucose oxydase, la galactose oxydase, la glycollate oxydase, l'aldéhyde oxydase, la lactate oxydase, la xantine oxydase, l'acide aminé-L oxydase, l'acide aminé-D oxydase, la monophosphate oxydase, l'hexose oxydase, la xylitol oxydase, la pyranose oxydase, l'alcool oxydase et leurs mélanges, et en ce que la quantité de ladite enzyme varie d'environ 0,2 UI à environ 2000 UI .5 - Composition according to one of claims 1 to 4, characterized in that the oxidoreductase enzyme is chosen from the group consisting of glucose oxidase, galactose oxidase, glycollate oxidase, aldehyde oxidase, lactate oxidase, xantine oxidase, amino acid-L oxidase, acid amine-D oxidase, monophosphate oxidase, hexose oxidase, xylitol oxidase, pyranose oxidase, alcohol oxidase and mixtures thereof, and in that the amount of said enzyme varies from about 0.2 IU to about 2000 UI.
6 - Composition selon l'une des revendications 1 à 5, caractérisée en ce que la source d'ions halogénure ou pseudohalogénure est choisie dans le groupe constitué par le thiocyanate de potassium, le thiocyanate de sodium, le thiocyanate d'ammonium, d'autres sels thiocyanates, l'iodure de potassium, d'autres sels iodures, le chlorure de sodium, d'autres sels chlorures et leurs mélanges, et en ce que la quantité de ladite source d'ions varie d'environ 0,0001 mol/g à environ 0,1 mol/g de matériau support.6 - Composition according to one of claims 1 to 5, characterized in that the source of halide or pseudohalide ions is chosen from the group consisting of potassium thiocyanate, sodium thiocyanate, ammonium thiocyanate, other thiocyanate salts, potassium iodide, other iodide salts, sodium chloride, other chloride salts and mixtures thereof, and in that the amount of said ion source varies from about 0.0001 mol / g to about 0.1 mol / g of support material.
7 - Composition selon l'une des revendications 1 à 6, caractérisée en ce que l'enzyme peroxydase est choisie dans le groupe constitué par la lactoperoxydase, la superoxyde dismutase, la myéloperoxydase, la chloroperoxydase, la peroxydase du raifort, la peroxydase de la salive et leurs mélanges, et en ce que la quantité de ladite enzyme varie d'environ 0,1 Ul/g à environ 100 Ul/g de matériau support.7 - Composition according to one of claims 1 to 6, characterized in that the peroxidase enzyme is chosen from the group consisting of lactoperoxidase, superoxide dismutase, myeloperoxidase, chloroperoxidase, horseradish peroxidase, peroxidase of saliva and mixtures thereof, and in that the amount of said enzyme varies from about 0.1 IU / g to about 100 IU / g of support material.
8 - Composition selon l'une des revendications 1 à 7, caractérisée en ce qu'elle comprend un agent stimulant la salivation, notamment choisi dans le groupe constitué par les émulsifiants saturés ou non, les acidifiants et leurs mélanges. 8 - Composition according to one of claims 1 to 7, characterized in that it comprises a salivation stimulating agent, in particular chosen from the group consisting of saturated or unsaturated emulsifiers, acidifiers and their mixtures.
9 - Composition selon l'une des revendications 1 à 8, caractérisée en ce qu'elle comprend un agent tampon afin d'obtenir une composition présentant un pH d'environ 4 à environ 8, de préférence d'environ 5,4 à environ 6,5. 9 - Composition according to one of claims 1 to 8, characterized in that it comprises a buffering agent in order to obtain a composition having a pH of approximately 4 to approximately 8, preferably approximately 5.4 to approximately 6.5.
10. Composition selon l'une des revendications 1 à 9, caractérisée en ce qu'elle comprend un agent enzymatique antibactérien choisi dans le groupe constitué par le lysozyme, la lactoferrine et leurs mélanges.10. Composition according to one of claims 1 to 9, characterized in that it comprises an antibacterial enzymatic agent chosen from the group consisting of lysozyme, lactoferrin and their mixtures.
11. Composition selon l'une des revendications 1 à 10, caractérisée en ce qu'elle comprend un agent aromatisant choisi dans le groupe constitué par les arômes de poulet, les arômes de poisson et leurs mélanges.11. Composition according to one of claims 1 to 10, characterized in that it comprises a flavoring agent chosen from the group consisting of chicken flavors, fish flavors and their mixtures.
12. Composition selon l'une des revendications 1 à 11, caractérisée en ce qu'elle comprend des véhicules et excipients appropriés pour une administration par voie orale. 12. Composition according to one of claims 1 to 11, characterized in that it comprises vehicles and excipients suitable for oral administration.
13. Composition selon l'une des revendications 1 à 12, caractérisée en ce qu'elle se présente sous forme orale liquide .13. Composition according to one of claims 1 to 12, characterized in that it is in liquid oral form.
14. Composition selon l'une des revendications 1 à 12, caractérisée en ce qu'elle se présente sous forme orale solide .14. Composition according to one of claims 1 to 12, characterized in that it is in solid oral form.
15. Composition selon l'une quelconque des revendications 1 à 14, caractérisée en ce qu'elle se présente sous forme d'un dentifrice, d'une lamelle à mâcher, d'un chewing-gum, d'un collutoire pour bain de bouche, d'un gel buccal, d'une poudre dentaire, d'un comprimé à mâcher, d'une pâte à mâcher. 15. Composition according to any one of claims 1 to 14, characterized in that it is in the form of a toothpaste, a chewing strip, a chewing gum, a mouthwash for bath mouth, oral gel, dental powder, chewable tablet, chewy paste.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0311384A FR2860154B1 (en) | 2003-09-29 | 2003-09-29 | COMPOSITION FOR THE TREATMENT OF MALE BREATH |
PCT/IB2004/003637 WO2005030154A1 (en) | 2003-09-29 | 2004-09-29 | Composition for treating bad breath |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1677751A1 true EP1677751A1 (en) | 2006-07-12 |
Family
ID=34307240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04787564A Ceased EP1677751A1 (en) | 2003-09-29 | 2004-09-29 | Composition for treating bad breath |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070081952A1 (en) |
EP (1) | EP1677751A1 (en) |
JP (1) | JP2007507488A (en) |
FR (1) | FR2860154B1 (en) |
WO (1) | WO2005030154A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2673497A1 (en) * | 2006-10-10 | 2008-04-17 | Laclede, Inc. | Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases |
JP5809775B2 (en) * | 2008-02-14 | 2015-11-11 | 株式会社ロッテ | Effervescent solid preparation for oral cleaning |
EP2341985A1 (en) * | 2008-08-12 | 2011-07-13 | Bardow Consult v/Allan Bardow | Dental formulations for the prevention of dental erosion |
JP5447392B2 (en) * | 2008-12-26 | 2014-03-19 | ライオン株式会社 | Chewing gum composition |
JP2011219386A (en) * | 2010-04-06 | 2011-11-04 | Lion Corp | Care composition in mouth |
US8926949B2 (en) * | 2010-06-15 | 2015-01-06 | Rebecca Dayanim | Composition for oral health treatment and related methods of use |
US20120070423A1 (en) * | 2010-09-21 | 2012-03-22 | Puneet Nanda | Oral composition and method of forming and using same |
US20140065078A1 (en) * | 2012-08-31 | 2014-03-06 | Dr. Fresh, Llc | Oral care composition for promoting and maintaining oral health and method of forming and using same |
JP5860509B2 (en) * | 2014-06-25 | 2016-02-16 | 株式会社ロッテ | Effervescent solid preparation for oral cleaning |
JP6711540B2 (en) * | 2016-03-31 | 2020-06-17 | 株式会社松風 | Oral composition |
CA3058622A1 (en) * | 2017-05-09 | 2018-11-15 | Novozymes A/S | Animal chew toy with dental care composition |
SG11202009330UA (en) * | 2018-03-23 | 2020-10-29 | Morinaga Milk Industry Co Ltd | Composition for inactivating smell component |
US20210169777A1 (en) * | 2019-12-05 | 2021-06-10 | Chun Nan LIN | Artificial Saliva with Electrolytes for Xerostomia |
WO2023153945A1 (en) * | 2022-02-14 | 2023-08-17 | Quantec Limited | Combination, therapeutic uses and prophylactic uses |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50898B1 (en) * | 1969-04-09 | 1975-01-13 | ||
NL150332B (en) * | 1969-06-03 | 1976-08-16 | Telec S A | PROCESS FOR PREPARING AN ENZYMIC DENTAL CLEANSING AGENT, AND OBJECTS THEREOF. |
FR2051992A6 (en) * | 1969-07-03 | 1971-04-09 | Erasme | Enzyme-contng toothpaste |
US4564519A (en) * | 1983-06-06 | 1986-01-14 | Laclede Professional Products, Inc. | Di-enzymatic chewable dentifrice |
JPS59231011A (en) * | 1983-06-06 | 1984-12-25 | ラクレ−デ・プロフエツシヨナル・プロダクツ・インコ−ポレ−テツド | Two enzyme dentifrice |
US4740368A (en) * | 1985-12-11 | 1988-04-26 | Plevy Donald J | Amylase containing breath cleansing confection |
DK501686A (en) * | 1986-10-20 | 1988-04-21 | Otto Melchior Poulsen | ENZYME CONTAINING BACTERICIDIC AGENTS AND DENTALS AND SPECIAL TREATMENTS CONTAINING IT |
GB9015910D0 (en) * | 1990-07-19 | 1990-09-05 | Univ Bruxelles | Novel use |
US5176899A (en) * | 1991-11-25 | 1993-01-05 | Montgomery Robert E | Antimicrobial dentifrice |
US5310541A (en) * | 1992-08-27 | 1994-05-10 | Montgomery Robert E | Antimicrobial rawhide animal chew containing an oxidoreductase and oxidoreductase substrate |
US5336494A (en) * | 1993-01-29 | 1994-08-09 | Pellico Michael A | Pet chewable products with enzymatic coating |
US5843471A (en) * | 1997-11-06 | 1998-12-01 | Chaykin; Sterling | Oral cleansing: methods and compositions |
US20030003059A1 (en) * | 2001-04-03 | 2003-01-02 | Frederic Dana | Dentifrice compositions |
-
2003
- 2003-09-29 FR FR0311384A patent/FR2860154B1/en not_active Expired - Lifetime
-
2004
- 2004-09-29 EP EP04787564A patent/EP1677751A1/en not_active Ceased
- 2004-09-29 WO PCT/IB2004/003637 patent/WO2005030154A1/en active Application Filing
- 2004-09-29 US US10/578,621 patent/US20070081952A1/en not_active Abandoned
- 2004-09-29 JP JP2006530768A patent/JP2007507488A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO2005030154A1 * |
Also Published As
Publication number | Publication date |
---|---|
FR2860154A1 (en) | 2005-04-01 |
JP2007507488A (en) | 2007-03-29 |
WO2005030154A1 (en) | 2005-04-07 |
FR2860154B1 (en) | 2006-02-03 |
US20070081952A1 (en) | 2007-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1677751A1 (en) | Composition for treating bad breath | |
US6576227B1 (en) | Peroxidase-activating oral compositions | |
EP1194163B1 (en) | Novel methods and medicament for treating infectious diseases involving microbial biofilms | |
US4564519A (en) | Di-enzymatic chewable dentifrice | |
EP0270643B1 (en) | Method for conditioning an antibacterial composition and antibacterial composition thus conditioned | |
EP0746303B1 (en) | Stabilized enzymatic antimicrobial compositions | |
BE1001394A5 (en) | SOLID COMPOSITION antitartar DEODORIZER MOUTH AND ITS APPLICATION. | |
FR2694692A1 (en) | Cosmetic compsn for skin nutrition - contains essential fatty acids, vitamin(s) and chelated trace and major elements | |
EP0272968A2 (en) | Hygienic composition, especially for the care of dogs' teeth | |
FR3020758A1 (en) | COMPOSITION FOR IMPROVING BUCO-DENTAL HYGIENE | |
FR2932385A1 (en) | COMPOSITION COMPRISING MICROENCAPSULATED NATURAL EXTRACTS FOR ORAL OR MUCOSAL APPLICATION | |
CA2661694A1 (en) | Salivary substitute | |
EP1242043B1 (en) | Enzyme composition for bucco-dental hygiene | |
EP0332551B1 (en) | Solid galenic forms containing at least one peroxidic substance and a transition metal salt | |
EP1408921B1 (en) | Composition for oral hygiene comprising a fluoride ion vector and an antioxidant | |
WO2019165338A1 (en) | Oxygenating oral and topical compositions | |
US20140065078A1 (en) | Oral care composition for promoting and maintaining oral health and method of forming and using same | |
FR2822700A1 (en) | Ingestible buccal hygiene compositions, useful for human or animal use. comprise a gel that adheres to the teeth and gums and releases active materials over a prolonged period | |
FR2848110A1 (en) | Buccal and dental hygiene product, comprising toothpaste, collutory or animal feed contains melatonin having antioxidant, radical scavenging and immunostimulant action | |
FR3106059A1 (en) | EDIBLE TO SUCK OR CHEW TOOTHPASTE COMPOSITION, PROCESS FOR PREPARING THE SAID TOOTHPASTE COMPOSITION | |
WO2013098519A2 (en) | Use of a composition for preventing and combating the effects of tobacco on the skin | |
WO2024160840A1 (en) | Enzyme composition for treating dental plaque and plaque bacterial biofilms, and for the natural whitening of tooth enamel | |
WO2013001167A1 (en) | Non-toxic compositions for decreasing the risk of cancer caused by oral microbes | |
WO2022192453A1 (en) | Compositions and methods of use thereof for antiseptic mouth rinses | |
EP2381939A1 (en) | Cosmetic composition containing ketogluconic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060329 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
17Q | First examination report despatched |
Effective date: 20060927 |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ECUPHAR NV |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: CARDON, CHRISTIAAN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20090630 |